Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
224.9 USD | +2.21% | +3.27% | -13.07% |
May. 31 | Biogen: Brussels grants marketing authorization for Charcot disease | CF |
May. 31 | Disaster averted |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- BIIB Stock
- Revisions Biogen Inc.